Englewood Health reaccredited for transcatheter valve program

Bergen County’s first hospital to receive this recognition continues to lead in minimally invasive heart valve care

Englewood Health has earned reaccreditation from the American College of Cardiology (ACC) for its Transcatheter Valve Certification, reaffirming its position as a leader in minimally invasive heart valve treatments. The hospital first received the distinction in 2022, becoming the first in Bergen County to achieve this recognition. 

“We are seeing more patients turn to Englewood Health for advanced valve treatments because of our expertise, minimally invasive approach and commitment to personalized care,” said Dr. Ramin Hastings, medical director of the Structural Heart and Valve Program at Englewood Health. “As one of the most experienced centers in the region, we offer a comprehensive range of transcatheter valve therapies, giving patients access to more options, faster recovery times and the latest innovations.” 

Advanced Valve Treatments at Englewood Health 

The Structural Heart and Valve Program offers a full range of transcatheter valve therapies, including:

  • Transcatheter Aortic Valve Replacement (TAVR): A minimally invasive procedure to replace a narrowed aortic valve due to aortic stenosis. Englewood Health has performed more than 1,700 TAVR procedures, providing a safer alternative to open-heart surgery. 
  • Transcatheter Edge-to-Edge Repair (TEER): A catheter-based approach to reducing regurgitation in the mitral or tricuspid valve. Englewood Health offers MitraClip and PASCAL for mitral regurgitation and TriClip for tricuspid regurgitation. 
  • Transcatheter Tricuspid Valve Replacement (TTVR): Englewood Health is among the first hospitals in New Jersey to offer EVOQUE, the first FDA-approved transcatheter valve replacement for tricuspid regurgitation. 

The ACC reaccreditation follows a rigorous evaluation process, assessing multidisciplinary teamwork, formalized training, shared decision-making and national performance benchmarks.  

“This reaccreditation underscores our dedication to delivering outstanding structural heart care with exceptional outcomes,” said Dr. Joseph De Gregorio, executive director of cardiovascular services at Englewood Health. “Our team of interventional cardiologists, cardiothoracic surgeons and specialized clinical staff collaborates to provide cutting-edge treatments while ensuring the highest level of safety and quality.”